Alpha DNA Investment Management’s Eaton ETN Stock Holding History

Alpha DNA Investment Management’s Portfolio ETN Stock Details ETN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,688	Closed	-$891K	–	211
2024 Q3	$891K	Buy	+2,688	New	+$821K	0.33%	62
2024 Q2	–	Sell	-3,155	Closed	-$987K	–	218
2024 Q1	$987K	Buy	+3,155	New	+$863K	0.36%	49
2023 Q4	–	Sell	-3,547	Closed	-$757K	–	205
2023 Q3	$757K	Sell	3,547 -1,648	-32%	-$355K	0.31%	73
2023 Q2	$1.04M	Buy	+5,195	New	+$914K	0.35%	65
2022 Q4	–	Sell	-5,202	Closed	-$693K	–	167
2022 Q3	$693K	Buy	+5,202	New	+$728K	0.58%	65
2021 Q3	–	Sell	-12,298	Closed	-$1.82M	–	119
2021 Q2	$1.82M	Buy	12,298 +12,217	+15,083%	+$1.76M	1.24%	10
2021 Q1	$10K	Sell	81 -5,249	-98%	-$677K	0.01%	288
2020 Q4	$640K	Buy	+5,330	New	+$602K	0.68%	70

Other funds holding ETN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Alpha DNA Investment Management's ETN Position: Q4 2024 in Review

Alpha DNA Investment Management sold out of Eaton (ETN) in Q4 2024, closing a stake of 2,688 shares — an estimated $891K sold.

Alpha DNA Investment Management first reported a position in ETN in Q4 2020 and held it in 8 quarters. The position peaked at $1.82M in Q2 2021. 2,279 funds tracked by Wall St. Rank hold ETN as of Q4 2024.

Alpha DNA Investment Management reported no remaining Eaton position as of Q4 2024 after selling out during the quarter.
Alpha DNA Investment Management sold 2,688 Eaton shares in Q4 2024, an estimated $891K.
Alpha DNA Investment Management first reported a position in Eaton in Q4 2020 and held it in 8 quarters.
Alpha DNA Investment Management's Eaton position peaked at $1.82M in Q2 2021.
2,279 funds tracked by Wall St. Rank held Eaton as of Q4 2024.

Based on Alpha DNA Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.